Immunize Colorado Revenue and Competitors
Estimated Revenue & Valuation
- Immunize Colorado's estimated annual revenue is currently $2.1M per year.
- Immunize Colorado's estimated revenue per employee is $162,000
Employee Data
- Immunize Colorado has 13 Employees.
- Immunize Colorado grew their employee count by 0% last year.
Immunize Colorado's People
Name | Title | Email/Phone |
---|
Immunize Colorado Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $32.9M | 122 | 8% | N/A | N/A |
#2 | $125.9M | 373 | 7% | N/A | N/A |
#3 | $24.8M | 92 | 7% | N/A | N/A |
#4 | $2.6M | 16 | -41% | N/A | N/A |
#5 | $0.1M | 1 | -98% | N/A | N/A |
#6 | $45.1M | 152 | 14% | N/A | N/A |
#7 | $2.4M | 15 | -6% | N/A | N/A |
#8 | $9.9M | 46 | 2% | N/A | N/A |
#9 | $176.5M | 523 | 4% | N/A | N/A |
#10 | $9.1M | 42 | -9% | N/A | N/A |
What Is Immunize Colorado?
Immunize Colorado is dedicated to keeping Colorado communities healthy by building awareness for vaccines, educating health care providers, and advocating for policies that protect all Coloradans with the goal of increasing vaccination rates. As Colorado's only statewide independent 501c(3) nonprofit organization committed to protecting the health of all Coloradans through immunization, we elevate the essential role vaccines play in preventing illness and promoting health for all Colorado. Immunize Colorado does not accept funding from vaccine manufacturers and distributors.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immunize Colorado News
Senate Bill 168 will also move the state's Search and Rescue Fund over to CPW, immunize rescuers from civil lawsuits and provide disability...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 13 | -13% | N/A |
#2 | $2.1M | 13 | 0% | N/A |
#3 | $2.1M | 13 | 0% | N/A |
#4 | $3.3M | 13 | 8% | N/A |
#5 | $2M | 13 | 8% | N/A |